PHARMAC’s proposed approach to market share procurement for hospital medical devices

Feedback sought

PHARMAC welcomes feedback on this discussion document. To provide feedback, please submit it in writing by 5 pm, 7 May 2015 to:

Background

This discussion document presents PHARMAC’s proposed approach to market share procurement for hospital medical devices, and seeks feedback on this. The feedback we receive will help us to refine that approach.

In July 2014 we established a Wound Care Advisory Group (WCAG) made up of wound care specialists nominated by the National Wound Care Society of New Zealand, to provide objective clinical advice around wound care products. We propose that wound care would be the first category to be considered for market share procurement. This is because we have substantially completed national contracting activity in this area and have enough information about the market and clinical advice to enable us to run a market share approach.

Engaging with clinicians and the wider health sector continues to be the cornerstone of PHARMAC’s work with hospital medical devices. Feedback received through previous consultations has emphasised the importance of seeking clinical advice and the range of relevant clinical factors that need to be considered.

We invite anyone with an interest to provide their views on the discussion document.